Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. Sustained viral response (SVR) achievement led to decreasing incidence and prevalence of T2DM during the interferon era of HCV treatme...
Saved in:
Main Authors: | Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/6150861 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
by: Sylvia Drazilova, et al.
Published: (2018-01-01) -
Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging
by: René Hako, et al.
Published: (2019-01-01) -
External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
by: Jakub Gazda, et al.
Published: (2021-01-01) -
Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy
by: Xiping Ran, et al.
Published: (2025-02-01) -
DaaC:an architecture modeling of space information network
by: Shao-bo YU, et al.
Published: (2017-10-01)